Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.2 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency KEL Library | On Loan, due Wednesday, June 5, 2024 |
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency VIC Cancer Info Ctr | On Loan, due Tuesday, June 11, 2024 | ||
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available |
Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources. A report of ICRP publication 98. Ann ICRP> 2005; 35(3) : iii-vi, 3-50. Review Erratum in: Ann ICRP 2005; 35(4) :141.
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | On Loan, due Thursday, May 30, 2024 | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency VAN Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | On Loan, due Thursday, May 30, 2024 | ||
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available |
Overview; Diagnostic studies; Neurologic symptoms; Direct complications of cancer; Indirect complications of cancer; Complications of cancer therapy; Neurologic complications of specific malignancies
Radiation in the treatment of cancer; Uncertainty; Mapping anatomy; Designing a treatment beam; Biology matters; Designing a treatment plan; Motion management; Planning manually; IMRT and optimization; Proton therapy in water; Proton therapy in the patient; Quality assurance; Confidence